Cristina Gasparetto

3PUBLICATIONS
3CO-AUTHORS
Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 24, 2025
Treatment of Relapsed/Refractory t(11;14) Multiple Myeloma and High-Risk Myelodysplastic Syndrome With Venetoclax.

Allison O Taylor, Stephanie Clune, JoAnn Liu

|Jul 18, 2022
Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma.

Cristina Gasparetto, Suzanne Lentzsch, Gary Schiller

|Nov 21, 2021
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients.

Cristina Gasparetto, Gary J Schiller, Sascha A Tuchman

Pageof 1